Skip to main content

Headlines

Ionis Reports Positive Topline Data From The HALOS Phase 1/2a Study In Angelman Syndrome
posted:
by: Nasdaq News
#channels:: #All, #Business, #News, #Nasdaq, #NasdaqNews, #Stocks
AZN:Phase III Trial Of Sipavibart Met Main Goal In Preventing COVID-19 In Immunocompromised Patients
posted:
by: Nasdaq FB FaceBook
#channels:: #All, #Business, #Technology, #Nasdaq, #Stocks, #FB, #FaceBook, #MetaPlatforms, #META
Roche's Phase I Trial Of CT-388 To Treat Obesity And Type 2 Diabetes Report Positive Results
posted:
by: Nasdaq FB FaceBook
#channels:: #All, #Business, #Technology, #Nasdaq, #Stocks, #FB, #FaceBook, #MetaPlatforms, #META
Actinium : Iomab-B Phase 3 Trial Results Show Significant Survival Benefit In High-Risk AML Patients
posted:
by: Nasdaq Markets
#channels:: #All, #Business, #Nasdaq, #NasdaqMarkets, #Stocks, #Markets
Lyra Therapeutics's Phase 3 Enlighten Trial 1 Fails To Meet Primary Endpoint; Stock Down
posted:
by: Nasdaq FB FaceBook
#channels:: #All, #Business, #Technology, #Nasdaq, #Stocks, #FB, #FaceBook, #MetaPlatforms, #META
Calliditas Announces Positive Data From Proof-of-concept Phase 2 Trial With Setanaxib
posted:
by: Nasdaq Markets
#channels:: #All, #Business, #Nasdaq, #NasdaqMarkets, #Stocks, #Markets
Moderna's MRNA-1283 COVID-19 Vaccine Design Meets Primary Endpoints In Phase 3 Clinical Trial
posted:
by: Nasdaq FB FaceBook
#channels:: #All, #Business, #Technology, #Nasdaq, #Stocks, #FB, #FaceBook, #MetaPlatforms, #META
Axsome Therapeutics' Phase 3 SYMPHONY Study In Narcolepsy Meets Primary Goal
posted:
by: Nasdaq FB FaceBook
#channels:: #All, #Business, #Technology, #Nasdaq, #Stocks, #FB, #FaceBook, #MetaPlatforms, #META
Nvidia Led the First Phase of Artificial Intelligence (AI), but These 2 Growth Stocks Will Lead the Next Phases, According to a Wall Street Team
posted:
by: Nasdaq AMZN Amazon
#channels:: #All, #Business, #Technology, #Nasdaq, #Stocks, #AMZN, #Amazon
Crinetics Pharma Stock Rises On Announcement Of Positive Data From Phase 3 Studies Of Paltusotine
posted:
by: Nasdaq News
#channels:: #All, #Business, #News, #Nasdaq, #NasdaqNews, #Stocks
Innovent : Phase 2 Trial Of IBI302 In Neovascular Age-related Macular Degeneration Meets Main Goal
posted:
by: Nasdaq Markets
#channels:: #All, #Business, #Nasdaq, #NasdaqMarkets, #Stocks, #Markets
Sanofi's Phase 2b Results Support Amlitelimab's Potential In Atopic Dermatitis
posted:
by: Nasdaq News
#channels:: #All, #Business, #News, #Nasdaq, #NasdaqNews, #Stocks
ARS Pharma's Neffy Shows Rapid Symptom Control In Phase 2 Urticaria Clinical Study
posted:
by: Nasdaq Markets
#channels:: #All, #Business, #Nasdaq, #NasdaqMarkets, #Stocks, #Markets
GSK: Gepotidacin EAGLE-1 Phase III Trial In GC Reports Positive Headline Results
posted:
by: Nasdaq Markets
#channels:: #All, #Business, #Nasdaq, #NasdaqMarkets, #Stocks, #Markets
Larimar Therapeutics Reports Positive Data From Nomlabofusp Phase 2 Study In FA Patients
posted:
by: Nasdaq News
#channels:: #All, #Business, #News, #Nasdaq, #NasdaqNews, #Stocks